QI
ABMD

QS Investors’s Abiomed Inc ABMD Stock Holding History

QS Investors’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$479K Buy
1,534
+160
+12% +$49.1K 0.01% 749
2021
Q1 		$438K Hold
1,374
– – 0.01% 845
2020
Q4 		$445K Buy
1,374
+133
+11% +$36.8K 0.01% 842
2020
Q3 		$344K Sell
1,241
-288
-19% -$83K ﹤0.01% 872
2020
Q2 		$370K Hold
1,529
– – 0.01% 991
2020
Q1 		$222K Hold
1,529
– – ﹤0.01% 1035
2019
Q4 		$259K Sell
1,529
-8,003
-84% -$1.48M ﹤0.01% 1130
2019
Q3 		$1.7M Sell
9,532
-500
-5% -$108K 0.02% 615
2019
Q2 		$2.61M Buy
10,032
+382
+4% +$101K 0.03% 490
2019
Q1 		$2.76M Buy
9,650
+1,696
+21% +$564K 0.03% 475
2018
Q4 		$2.59M Buy
7,954
+6,500
+447% +$2.26M 0.03% 437
2018
Q3 		$654K Sell
1,454
-300
-17% -$118K 0.01% 908
2018
Q2 		$717K Buy
1,754
+250
+17% +$90.6K 0.01% 865
2018
Q1 		$438K Hold
1,504
– – ﹤0.01% 968
2017
Q4 		$282K Hold
1,504
– – ﹤0.01% 1086
2017
Q3 		$254K Hold
1,504
– – ﹤0.01% 1140
2017
Q2 		$216K Hold
1,504
– – ﹤0.01% 1181
2017
Q1 		$188K Buy
1,504
+1,500
+37,500% +$174K ﹤0.01% 1252
2016
Q4 		$1K Hold
4
– – ﹤0.01% 1824
2016
Q3 		$1K Hold
4
– – ﹤0.01% 1820
2016
Q2 		$1K Hold
4
– – ﹤0.01% 1875
2016
Q1 		$1K Hold
4
– – ﹤0.01% 1848
2015
Q4 		$1K Buy
+4
New +$339 ﹤0.01% 1907

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

QS Investors's ABMD Position: Q2 2021 in Review

QS Investors increased its Abiomed Inc (ABMD) stake by 12% in Q2 2021, buying an estimated $49.1K and bringing the position to 1,534 shares worth $479K. The position accounts for 0.01% of the portfolio, ranked #749.

QS Investors first reported a position in ABMD in Q4 2015 and has held it in 23 quarters since. The position peaked at $2.76M in Q1 2019. 474 funds tracked by Wall St. Rank hold ABMD as of Q2 2021.

  • QS Investors held 1,534 shares of Abiomed Inc worth $479K as of Q2 2021.
  • QS Investors bought 160 Abiomed Inc shares in Q2 2021, an estimated $49.1K.
  • Abiomed Inc made up 0.01% of QS Investors's portfolio in Q2 2021, its #749 holding.
  • QS Investors first reported a position in Abiomed Inc in Q4 2015 and has held it in 23 quarters since.
  • QS Investors's Abiomed Inc position peaked at $2.76M in Q1 2019.
  • 474 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2021.

Based on QS Investors's 13F filing for Q2 2021, filed 13 Aug 2021.